Prothena

long shot miss basketball hoop fail shoot

Roche's Prothena-partnered Parkinson's prospect fails phase 2b

Days after the failure of UCB's Novartis-partnered program, Roche has shared details of its own alpha-synuclein flop while clinging onto signs of clinical benefit.

Nick Paul Taylor Dec 19, 2024 4:31am

UCB-Novartis Parkinson's asset fails to improve symptoms in ph. 2

Dec 16, 2024 3:19pm

Paragliding near Tu Le valley with landscape with green and yellow rice fields and blue cloudy sky North- Vietnam

Prothena promotes one exec while another leaves—Chutes & Ladders

Oct 4, 2024 8:00am

Inspector uses a magnifying glass for inspecting papers

NIH leader's research misconduct calls drugs into question

Sep 26, 2024 9:12am

Bristol Myers checks 'yes' on Prothena neurodegenerative therapy

May 29, 2024 10:38am

BMS pays $95M to exercise Evotec, Prothena neuroscience options

Jul 11, 2023 5:30am